With an increasing focus on biomarkers in dementia research, illustrating the role of
neuropsychological assessment in detecting mild cognitive impairment (MCI) and …

The construct of mild cognitive impairment (MCI) has been proposed to identify patients at
risk of developing Alzheimer's disease (AD) in the pre-clinical stage. Although subjects with …

We compared two methods of diagnosing mild cognitive impairment (MCI): conventional
Petersen/Winblad criteria as operationalized by the Alzheimer's Disease Neuroimaging …

Subjective cognitive complaints are a criterion for the diagnosis of mild cognitive impairment
(MCI), despite their uncertain relationship to objective memory performance in MCI. We …

Abstract The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening
instrument developed by Nasreddine et al. to detect mild cognitive impairment, a high-risk …

Background We assessed whether mild cognitive impairment (MCI) subtypes could be
empirically derived within the Alzheimer's Disease Neuroimaging Initiative (ADNI) MCI …

We performed a systematic review of studies focusing on the automatic prediction of the
progression of mild cognitive impairment to Alzheimer's disease (AD) dementia, and a …

The aim of this study was to determine the neural correlates of different stages of episodic
memory function and their modulation by Alzheimer's disease (AD). Several decades of …

Objective: To compare cued recall measures with other memory and nonmemory tests
regarding their association with a biomarker profile indicative of Alzheimer disease (AD) in …

Background Individuals with subjective memory impairment (SMI) report worsening of
memory without impairment in cognitive tests. Despite normal cognitive performance, they …